Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

NCT03048877 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Differentiated Thyroid Cancer

Interventions

DRUG: Apatinib Oral Tablet
DRUG: Placebo Oral Tablet

Sponsor

Peking Union Medical College Hospital